Ivan Krečak, Marija Valovičić Krečak, Iva Lazinica, Marko Lucijanić
{"title":"Preoperative polycythemia may be associated with inferior postoperative outcomes: a retrospective study.","authors":"Ivan Krečak, Marija Valovičić Krečak, Iva Lazinica, Marko Lucijanić","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To investigate the influence of preoperative polycythemia on postoperative outcomes.</p><p><strong>Methods: </strong>We retrospectively reviewed the postoperative outcomes of 1196 elective non-cardiac surgery procedures (minor, 36%; intermediate/major, 64%) performed under general anesthesia at the General Hospital of Šibenik-Knin County, Croatia, between January 1, 2023 and January 1, 2024. Patients were stratified preoperatively as having anemia, normal hemoglobin, or polycythemia. The primary outcome was a 30-day postoperative composite outcome consisting of death, thrombosis, major bleeding, and the need for red blood cell transfusion.</p><p><strong>Results: </strong>Anemia, normal hemoglobin levels, and polycythemia were recorded preoperatively in 152 (12.7%), 1000 (83.6%), and 44 (3.7%) of patients, respectively. Patients with polycythemia were the youngest, more frequently men and smokers, and had the lowest frequency of prior venous thromboembolism (VTE). Patients with anemia were the oldest and most frequently had comorbidities, cancer, and prior VTE, used anticoagulants, and underwent intermediate/major surgeries. The composite outcome was recorded in 91 procedures (7.6%) and was most frequent in patients with polycythemia (18.2% vs 9.2% vs 6.9%; P=0.016). Patients with polycythemia also most frequently had postoperative bleeding (18.2% vs 7.9% vs 6.5%; P=0.011) and did not need postoperative red blood cell transfusions (P=0.003). The associations of preoperative polycythemia with the postoperative composite outcome and bleeding remained significant in multivariate models adjusted for surgery risk, sex, comorbidities, physical status, and antiplatelet or anticoagulant use. Patients with polycythemia did not experience deaths or thrombotic events.</p><p><strong>Conclusion: </strong>Patients with polycythemia require comprehensive preoperative assessment. Future studies are needed to investigate the pathophysiological mechanisms underlying the observed effects.</p>","PeriodicalId":10796,"journal":{"name":"Croatian Medical Journal","volume":"66 3","pages":"186-193"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12246972/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Croatian Medical Journal","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To investigate the influence of preoperative polycythemia on postoperative outcomes.
Methods: We retrospectively reviewed the postoperative outcomes of 1196 elective non-cardiac surgery procedures (minor, 36%; intermediate/major, 64%) performed under general anesthesia at the General Hospital of Šibenik-Knin County, Croatia, between January 1, 2023 and January 1, 2024. Patients were stratified preoperatively as having anemia, normal hemoglobin, or polycythemia. The primary outcome was a 30-day postoperative composite outcome consisting of death, thrombosis, major bleeding, and the need for red blood cell transfusion.
Results: Anemia, normal hemoglobin levels, and polycythemia were recorded preoperatively in 152 (12.7%), 1000 (83.6%), and 44 (3.7%) of patients, respectively. Patients with polycythemia were the youngest, more frequently men and smokers, and had the lowest frequency of prior venous thromboembolism (VTE). Patients with anemia were the oldest and most frequently had comorbidities, cancer, and prior VTE, used anticoagulants, and underwent intermediate/major surgeries. The composite outcome was recorded in 91 procedures (7.6%) and was most frequent in patients with polycythemia (18.2% vs 9.2% vs 6.9%; P=0.016). Patients with polycythemia also most frequently had postoperative bleeding (18.2% vs 7.9% vs 6.5%; P=0.011) and did not need postoperative red blood cell transfusions (P=0.003). The associations of preoperative polycythemia with the postoperative composite outcome and bleeding remained significant in multivariate models adjusted for surgery risk, sex, comorbidities, physical status, and antiplatelet or anticoagulant use. Patients with polycythemia did not experience deaths or thrombotic events.
Conclusion: Patients with polycythemia require comprehensive preoperative assessment. Future studies are needed to investigate the pathophysiological mechanisms underlying the observed effects.
目的:探讨术前红细胞增多症对术后预后的影响。方法:我们回顾性回顾了1196例选择性非心脏手术的术后结果(次要,36%;中级/专业(64%),于2023年1月1日至2024年1月1日在克罗地亚Šibenik-Knin县总医院全麻下进行。术前将患者按贫血、血红蛋白正常或红细胞增多症进行分层。主要转归是术后30天的综合转归,包括死亡、血栓形成、大出血和需要红细胞输血。结果:术前贫血152例(12.7%),血红蛋白正常1000例(83.6%),红细胞增多症44例(3.7%)。红细胞增多症患者年龄最小,多为男性和吸烟者,既往静脉血栓栓塞(VTE)发生率最低。贫血患者年龄最大,最常伴有合并症、癌症和静脉血栓栓塞,使用抗凝剂,并接受过中期/大手术。在91例手术中记录了复合结果(7.6%),在红细胞增多症患者中最常见(18.2% vs 9.2% vs 6.9%;P = 0.016)。红细胞增多症患者术后出血也最常见(18.2% vs 7.9% vs 6.5%;P=0.011),术后无需输注红细胞(P=0.003)。在手术风险、性别、合并症、身体状况、抗血小板或抗凝使用等因素调整后的多变量模型中,术前红细胞增多症与术后综合结局和出血的相关性仍然显著。红细胞增多症患者未发生死亡或血栓事件。结论:红细胞增多症患者需要全面的术前评估。需要进一步研究观察到的效应背后的病理生理机制。
期刊介绍:
Croatian Medical Journal (CMJ) is an international peer reviewed journal open to scientists from all fields of biomedicine and health related research.
Although CMJ welcomes all contributions that increase and expand on medical knowledge, the two areas are of the special interest: topics globally relevant for biomedicine and health and medicine in developing and emerging countries.